Fluvoxamine Other names: Fluvoxamine maleate

Chemical formula: C₁₅H₂₁F₃N₂O₂  Molecular mass: 318.34 g/mol  PubChem compound: 3404

Therapeutic indications

Fluvoxamine is indicated for:

Obsessive Compulsive Disorder (OCD)

Population group: only adults (18 years old or older)

Anancastic neurosis

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Major depressive episode

Population group: only adults (18 years old or older)

Major depressive disorder

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Obsessive Compulsive Disorder (OCD)

Population group: only children (1 year - 12 years old) , adolescents (12 years - 18 years old)

Anancastic neurosis

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Fluvoxamine is contraindicated in the following cases:

Monoamine oxidase inhibitors (MAOIs), tizanidine

at least one of
Monoamine oxidase inhibitors (MAOIs)
Tizanidine

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2018: FLUVOXAMINE Film-coated tablets
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈